AbbVie ABBV reported second-quarter earnings of $2.26 per share, which beat the analyst consensus estimate of $2.20. This is a 13% increase over earnings of $2 per share from the same period last year.
The company reported quarterly sales of $8.255 billion which beat the analyst consensus estimate of $8.1 billion. This is a 0.04% decrease over sales of $8.258 billion the same period last year.
AbbVie raised fiscal year 2019 EPS guidance from $8.73-$8.83 to $8.82-$8.92 versus a $8.82 estimate.
AbbVie shares were trading up 2.3% at $68.21 in Friday’s pre-market session. The stock has a 52-week high of $100.23 and a 52-week low of $65.06.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.